Naloxone (ultra-low dose)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Naloxone (ultra-low dose), covering 2026-06-04 to 2026-06-04. Get the full timeline:
Most recent: Clinical Trial Results: Effect of Ultra-low Dose Naloxone on Remifentanil-Induced Hyperalgesia [Phase 2]